Protein kinase PLK1

from Wikipedia, the free encyclopedia
Protein kinase PLK1
Properties of human protein
Mass / length primary structure 603 amino acids
Identifier
Gene name PLK1
External IDs
Enzyme classification
EC, category 2.7.11.21 kinase
Response type Phosphorylation
Substrate ATP + protein
Products ADP + phosphoprotein
Occurrence
Homology family Polo-like kinase
Parent taxon Eukaryotes
Orthologue
human House mouse
Entrez 5347 18817
Ensemble ENSG00000166851 ENSMUSG00000030867
UniProt P53350 Q07832
Refseq (mRNA) NM_005030 NM_011121
Refseq (protein) NP_005021 NP_035251
Gene locus Chr 16: 23.68 - 23.69 Mb Chr 7: 122.16 - 122.17 Mb
PubMed search 5347 18817

The protein kinase PLK1 (also: Polo-like-Kinase 1 ) is an enzyme in eukaryotes , a so-called kinase that phosphorylates various proteins in the cell nucleus and thus exercises a regulatory function during cell division . PLK1 is activated by growth-promoting factors. In humans, PLK1 is particularly localized in the cell nuclei of placenta and intestinal tissue and is excessively produced in some tumors . Inhibitors for the enzyme are therefore considered possible drugs against cancer .

PLK1 belongs to the polo-like kinases . They are mitotic kinases, i.e. those that are involved in regulating the cell cycle . They are serine / threonine kinases that are highly conserved in various species.

structure

PLK1 consists of 603 amino acids , a catalytic domain at the amino terminus (which in turn can be subdivided into eleven subdomains) and three conserved polo boxes at the carboxy terminus. They control the function of PLK1 during mitosis and cellular localization.

function

PLK1 has a variety of functions in the cell, the most important of which are phosphorylation and thus activation of the cyclin-dependent phosphatase Cdc25, which is required for the formation of the bipolar spindle during the prometaphase of the cell cycle. In addition, Plk 1 interacts with APC, the anaphase-promoting complex, which is responsible for the breakdown of mitotic proteins.

PLK1 is highly expressed in proliferating tissue and appears to be overexpressed in a number of tumor tissues. Inhibitors of PLK1, such as BI 7278, are therefore important candidates for new therapeutic approaches in cancer therapy.

Individual evidence

  1. UniProt P53350
  2. Nigg EA: Polo-like kinases: positive regulators of cell division from start to finish . In: Curr. Opin. Cell Biol . 10, No. 6, December 1998, pp. 776-83. PMID 9914175 .

Web links